Can manipulating gut microbes improve cardiac function in patients with heart failure?

August 8, 2018, Wiley
Credit: CC0 Public Domain

A clinical study called the GutHeart Trial is poised to examine the potential relationship between the bacterial composition of the gut and inflammatory and metabolic pathways in the cardiovascular system.

As described in an ESC Heart Failure article, the phase II randomized controlled trial will enroll patients with heart who will receive an antibiotic, a probiotic yeast, or no treatment on top of recommended heart failure treatment.

"To the best of our knowledge, the GutHeart trial is the first intervention study to assess the profile of the in heart failure patients and the way this profile is affected by drugs that act locally in the gut," said first author Dr. Cristiane C. K. Mayerhofer, of Oslo University Hospital, in Norway. "The new knowledge can pave the way for new innovative treatment strategies and will lead to a better understanding of how gut leakage is associated with inflammatory processes and ."

The potential significance of the study extends beyond the cardiovascular system, noted co-author Dr. Ayodeji Awoyemi, of Oslo University Hospital Ulleval. "It will most definitely expand our knowledge with regard to the clinical implications of modulating the ," he said.

Explore further: Risk of heart failure up in ALVSD patients with diabetes

More information: Cristiane C.K. Mayerhofer et al, Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial, ESC Heart Failure (2018). DOI: 10.1002/ehf2.12332

Related Stories

Risk of heart failure up in ALVSD patients with diabetes

July 27, 2018
(HealthDay)—For patients with asymptomatic left ventricular systolic dysfunction (ALVSD), those with diabetes have increased risk of heart failure development and hospitalization, according to a study published in the June ...

Sex, drugs, and heart failure

June 22, 2018
Heart failure is almost as common in women as men, but its characteristics vary by sex. A new review summarizes the current state of sex-sensitive issues related to heart failure drugs included in treatment guidelines, and ...

Diabetes may have important effects in patients with acute heart failure

June 26, 2017
Researchers have found that patients with acute heart failure and diabetes, compared with those without diabetes, have distinct markers related to inflammation, cardiovascular function, and kidney health.

Many adults have insufficient knowledge about heart failure

March 22, 2017
In the largest German survey on heart failure to date, investigators found that the overall awareness of heart failure has not increased over the past decade and is not at a satisfactory level.

Ivabradine may not benefit certain heart failure patients

April 30, 2017
Researchers have completed a randomized clinical trial in patients with heart failure with preserved ejection fraction (HFpEF), which currently has no effective treatment for reducing morbidity and mortality.

Method helps determine heart failure patients' risks

April 30, 2017
A new analysis describes different classifications of patients who are hospitalized with acute heart failure based on various characteristics, which may help guide early decisions regarding triage and treatment.

Recommended for you

Increasing statins dose and patient adherence could save more lives

December 7, 2018
Thousands of heart attacks and deaths from cardiovascular disease could be prevented by patients taking higher doses of statins and taking the drugs as advised by doctors.

Progress made in transplanting pig hearts into baboons

December 6, 2018
A large team of researchers from several institutions in Germany, Sweden, Switzerland and the U.S. has transplanted pig hearts into baboons and kept them alive for an extended period of time. In their paper published in the ...

Obesity ups survival in heart failure, but that's no reason to pile on pounds

December 6, 2018
(HealthDay)—Obese people with heart failure may live longer than those who are thinner—especially if they are "metabolically healthy," a new study suggests.

New genetic insight could help treat rare debilitating heart and lung condition

December 6, 2018
The largest study of genetic variation in patients with pulmonary arterial hypertension has associated two important genes with the disease.

New drug target discovered for potential blood pressure treatment

December 5, 2018
Scientists have identified a key player in blood pressure regulation and have shown that switching it off reduces blood pressure in mice, according to new research in eLife.

Neighborhoods with more green space may mean less heart disease

December 5, 2018
People who live in leafy, green neighborhoods may have a lower risk of developing heart disease and strokes, according to new research published in the Journal of the American Heart Association, the Open Access Journal of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.